Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45559 | 23891611 | Gastroenterology | Do therapeutic bile acids hit the sweet spot of glucose metabolism in NAFLD? | 2013 | Details |
| A45560 | 23885358 | Curr Opin Clin Nutr Metab Care | Current world literature. Carbohydrates. | 2013 | Details |
| A45571 | 23840101 | Mediators Inflamm | Influence of gut microbiota on subclinical inflammation and insulin resistance. | 2013 | Details |
| A45584 | 23772495 | Nihon Naika Gakkai Zasshi | [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease]. | 2013 | Details |
| A45598 | 23720171 | Dtsch Med Wochenschr | [Diabetes and the liver]. | 2013 | Details |
| A45611 | 23680744 | Hosp Pract (1995) | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. | 2013 | Details |
| A45616 | 23634669 | Diabetes Technol Ther | Has the time come for routine imaging studies in diabetes? | 2013 | Details |
| A45642 | 23493538 | Adv Nutr | Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. | 2013 | Details |
| A45646 | 23475416 | Endocr Rev | Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. | 2013 | Details |
| A45651 | 23448486 | Curr Pharm Des | Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. | 2013 | Details |
| A45692 | 23260099 | J Pediatr | Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. | 2012 | Details |
| A45713 | 23144998 | PLoS One | Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. | 2012 | Details |
| A45723 | 23070526 | Sleep Breath | Obstructive sleep apnea and dyslipidemia: importance of the liver axis. | 2012 | Details |
| A45756 | 22923470 | Diabetes | Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. | 2012 | Details |
| A45762 | 22882641 | Diabet Med | Fatty liver: cause or consequence. | 2012 | Details |
| A45775 | 22813567 | Diabetes Metab Syndr | Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus. | 2012 | Details |
| A45779 | 22801247 | J Investig Med | Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. | 2012 | Details |
| A45793 | 22701473 | Exp Diabetes Res | Molecular intricacies and the role of ER stress in diabetes. | 2012 | Details |
| A45816 | 22570973 | J Pediatr Endocrinol Metab | Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. | 2012 | Details |
| A45847 | 22422583 | Hepatology | Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH? | 2012 | Details |
| A45849 | 22397876 | Nutr Metab Cardiovasc Dis | No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. | 2012 | Details |
| A45857 | 22362822 | J Clin Endocrinol Metab | Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. | 2012 | Details |
| A45870 | 22283096 | Diabetes Self Manag | Diabetes definitions. | 2012 | Details |
| A45879 | 22227071 | Nutr Metab Cardiovasc Dis | Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver disease. | 2012 | Details |
| A45881 | 22219592 | World J Gastroenterol | Impact of liver diseases on the development of type 2 diabetes mellitus. | 2011 | Details |
| A45887 | 22194736 | Exp Diabetes Res | Diabetes and nonalcoholic fatty liver disease. | 2011 | Details |
| A45897 | 22154323 | Metabolism | Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | 2011 | Details |
| A45915 | 22101559 | Curr Opin Lipidol | Current world literature. | 2011 | Details |
| A45917 | 22093451 | Liver Int | Understanding the relationship between PNPLA3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers? | 2011 | Details |
| A45927 | 22027575 | J Hepatol | Hepatitis B virus infection and fatty liver in the general population. | 2011 | Details |
| A45929 | 22005190 | Adv Cardiol | Metabolic disorders associated with obstructive sleep apnea in adults. | 2011 | Details |
| A45932 | 21985780 | Ann Nutr Metab | Low-carbohydrate diets: a matter of love or hate. | 2011 | Details |
| A45953 | 21886053 | South Med J | A paradigm shift in the outpatient approach to liver function tests. | 2011 | Details |
| A45957 | 21868456 | BMJ | Investigating mixed hyperlipidaemia. | 2011 | Details |
| A45968 | 21788578 | Diabetes | The metabolically benign and malignant fatty liver. | 2011 | Details |
| A45972 | 21770296 | Nihon Naika Gakkai Zasshi | [The cutting-edge of medicine; clinical and molecular pathology of type 2 diabetic liver]. | 2011 | Details |
| A45979 | 21751586 | J Assoc Physicians India | Liver, a window to the heart in type 2 diabetes. | 2011 | Details |
| A46008 | 21604916 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk. | 2011 | Details |
| A46013 | 21554270 | Eur J Clin Invest | Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease. | 2011 | Details |
| A46014 | 21525484 | Diabetes Care | Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. | 2011 | Details |
| A46017 | 21536711 | Endocr Rev | Genetic syndromes of severe insulin resistance. | 2011 | Details |
| A46045 | 21435084 | Helicobacter | The association between Helicobacter pylori infection and insulin resistance: a systematic review. | 2011 | Details |
| A46059 | 21366813 | Pediatr Diabetes | Use of metformin in pediatric age. | 2011 | Details |
| A46065 | 21332536 | J Gastroenterol Hepatol | Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test? | 2011 | Details |
| A46097 | 21111993 | Clin Liver Dis | Endocrine diseases and the liver. | 2011 | Details |
| A46099 | 21105450 | Vnitr Lek | [Complications of obesity--pathogenesis]. | 2010 | Details |
| A46101 | 21102646 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus. | 2010 | Details |
| A46125 | 20880166 | J Gastroenterol Hepatol | Failure of islet β-cell compensation for insulin resistance causes type 2 diabetes: what causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis? | 2010 | Details |
| A46133 | 20827721 | Hepatology | Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease. | 2010 | Details |
| A46151 | 20710138 | South Med J | Nonalcoholic steatohepatitis: a review of the literature and updates in management. | 2010 | Details |
| A46169 | 20623203 | Obes Surg | The relationship of plasma adiponectin with liver fibrosis in morbid obesity. | 2010 | Details |
| A46177 | 20566726 | CMAJ | Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. | 2010 | Details |
| A46192 | 20452916 | J Am Pharm Assoc (2003) | Clarifying metformin's role and risks in liver dysfunction. | 2010 | Details |
| A46213 | 20335584 | N Engl J Med | Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. | 2010 | Details |
| A46219 | 20217240 | Mol Biol Rep | Oxidative stress induced by high-glucose diet in liver of C57BL/6J mice and its underlying mechanism. | 2010 | Details |
| A46236 | 20136984 | J Gastroenterol Hepatol | Does non-alcoholic fatty liver disease predispose patients to type 2 diabetes in the absence of obesity? | 2010 | Details |
| A46274 | 19849765 | Intern Med J | Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance. | 2009 | Details |
| A46278 | 19822488 | Hepatobiliary Pancreat Dis Int | Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? | 2009 | Details |
| A46280 | 19802516 | J Gastroenterol | The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome. | 2009 | Details |
| A46288 | 19767790 | Appl Physiol Nutr Metab | Physical activity and abdominal obesity in youth. | 2009 | Details |
| A46293 | 19738529 | South Med J | The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease. | 2009 | Details |
| A46300 | 19700042 | Clin Chest Med | The obesity epidemic. | 2009 | Details |
| A46321 | 19553925 | Obesity (Silver Spring) | Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. | 2009 | Details |
| A46326 | 19540737 | Pathophysiology | Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients. | 2009 | Details |
| A46333 | 19474719 | Curr Opin Clin Nutr Metab Care | Metabolic benefits from Sirt1 and Sirt1 activators. | 2009 | Details |
| A46337 | 19461374 | J Pediatr Orthop | Associations among slipped capital femoral epiphysis, tibia vara, and type 2 juvenile diabetes. | 2009 | Details |
| A46341 | 19443308 | Orv Hetil | [Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease]. | 2009 | Details |
| A46345 | 19403641 | Am J Clin Nutr | Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. | 2009 | Details |
| A46366 | 19284314 | Metab Syndr Relat Disord | Metabolic syndrome and cancer. | 2009 | Details |
| A46367 | 19271298 | J Pediatr Gastroenterol Nutr | Intestinal microbiota during infancy and its implications for obesity. | 2009 | Details |
| A46369 | 19262374 | Curr Opin Endocrinol Diabetes Obes | Nonalcoholic fatty liver disease in type 2 diabetes mellitus. | 2009 | Details |
| A46385 | 19141031 | Liver Int | Diabetic hepatosclerosis: a 10-year autopsy series. | 2009 | Details |
| A46388 | 19116372 | Am J Physiol Endocrinol Metab | The genetics of neutral lipid biosynthesis: an evolutionary perspective. | 2008 | Details |
| A46398 | 19046821 | Med Hypotheses | Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis. | 2008 | Details |
| A46412 | 18971485 | Endocr Rev | The metabolic syndrome. | 2008 | Details |
| A46422 | 18791116 | Gut | Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)? | 2008 | Details |
| A46423 | 18787467 | Eur J Gastroenterol Hepatol | Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. | 2008 | Details |
| A46426 | 18758740 | Chirurg | [Obesity - principles of surgical therapy]. | 2008 | Details |
| A46440 | 18664869 | J Pediatr Gastroenterol Nutr | Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. | 2008 | Details |
| A46442 | 18627005 | Hepatology | Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. | 2008 | Details |
| A46456 | 18510615 | Am J Gastroenterol | In search of an ideal biomarker for nonalcoholic fatty liver disease. | 2008 | Details |
| A46469 | 18413180 | J Diabetes Complications | Clinical resolution of glycogenic hepatopathy following improved glycemic control. | 2008 | Details |
| A46475 | 18385424 | J Am Soc Nephrol | Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. | 2008 | Details |
| A46481 | 18367852 | Korean J Hepatol | [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease]. | 2008 | Details |
| A46493 | 18277391 | Obesity (Silver Spring) | Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. | 2008 | Details |
| A46498 | 18249212 | Metabolism | Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. | 2008 | Details |
| A46504 | 18209601 | J Clin Gastroenterol | Nonalcoholic fatty liver disease and OGTT. | 2008 | Details |
| A46513 | 18092195 | Endocr Res | Nonalcoholic fatty liver disease and diabetes mellitus. | 2007 | Details |
| A46530 | 17904449 | Am J Med | Impact of diabetes on the severity of liver disease. | 2007 | Details |
| A46536 | 17720354 | Am J Med | Abdominal adiposity and cardiometabolic risk: do we have all the answers? | 2007 | Details |
| A46543 | 17729388 | World J Gastroenterol | Should nonalcoholic fatty liver disease be regarded as a hepatic illness only? | 2007 | Details |
| A46544 | 17726184 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
| A46548 | 17675904 | J Cardiometab Syndr | Introduction: organ involvement in the cardiometabolic syndrome. | 2006 | Details |
| A46554 | 17666460 | Diabetes Care | Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. | 2007 | Details |
| A46564 | 17565629 | J Gastroenterol Hepatol | Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. | 2007 | Details |
| A46570 | 17526817 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: response to Targher et al. and Hu et al. | 2007 | Details |
| A46571 | 17519430 | Diabetes Care | Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. | 2007 | Details |
| A46575 | 17498512 | Gastroenterology | Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. | 2007 | Details |
| A46576 | 17498510 | Gastroenterology | Obesity, inflammation, and insulin resistance. | 2007 | Details |
| A46577 | 17498505 | Gastroenterology | The epidemiology of obesity. | 2007 | Details |